Jianfei Cai1, Yinjia Zhang2, Jun Zou1,3, Yan Shen1, Dan Luo1, Huafang Bao1, Yong Chen1, Jingfen Ye1, Jian-Long Guan1,3. 1. Department of Rheumatology and Immunology, Huadong Hospital affiliated with Fudan University, Shanghai, China. 2. Department of Diagnostic Ultrasound, Huadong Hospital affiliated with Fudan University, Shanghai, China. 3. Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital affiliated with Fudan University, Shanghai, China.
Abstract
OBJECTIVE: This study aimed to investigate the correlation of serum uric acid (SUA) with risk and dilatation diameter of ascending aortic dilatation (AAD) in Behçet's disease (BD) patients. METHODS: Seventeen BD patients complicated with AAD and 20 BD patients without AAD were consecutively enrolled and categorized into AAD group and control group, respectively. Ascending aortic dilatation was determined by two-dimensional doppler echocardiographic examination, and AAD was defined as a diameter of ascending aorta ≥3.8 and <4.4 cm. SUA was detected by quantitative immunoassay method. RESULTS: Ascending aortic dilatation patients presented with higher proportion of male patients (P = 0.003), hypertension occurrence (P = 0.036) and increased diameter of ascending aorta (P < 0.001) compared to controls. SUA was elevated in AAD patients compared to controls (P = 0.002), and receiver operating characteristic curve displayed that SUA presented with great predictive value for AAD risk in BD patients with area under curve (AUC) 0.821 (95% CI 0.675-0.966). Pearson's analysis also disclosed that SUA was positively correlated with ascending aortic diameter in total BD patients. However, no difference of CRP (P = 0.219) or ESR (P = 0.320) between AAD patients and controls was observed, and no correlation of CRP (R = -0.150, P = 0.377) or ESR (R = 0.067, P = 0.692) with ascending aortic diameter in total BD patients was discovered either. Further multivariate logistic regression illuminated that SUA was an independent factor predicting AAD risk in BD patients (P = 0.031). CONCLUSIONS: Serum uric acid could be served as an independent marker for increased risk and severity of AAD in BD patients.
OBJECTIVE: This study aimed to investigate the correlation of serum uric acid (SUA) with risk and dilatation diameter of ascending aortic dilatation (AAD) in Behçet's disease (BD) patients. METHODS: Seventeen BDpatients complicated with AAD and 20 BDpatients without AAD were consecutively enrolled and categorized into AAD group and control group, respectively. Ascending aortic dilatation was determined by two-dimensional doppler echocardiographic examination, and AAD was defined as a diameter of ascending aorta ≥3.8 and <4.4 cm. SUA was detected by quantitative immunoassay method. RESULTS: Ascending aortic dilatation patients presented with higher proportion of male patients (P = 0.003), hypertension occurrence (P = 0.036) and increased diameter of ascending aorta (P < 0.001) compared to controls. SUA was elevated in AAD patients compared to controls (P = 0.002), and receiver operating characteristic curve displayed that SUA presented with great predictive value for AAD risk in BDpatients with area under curve (AUC) 0.821 (95% CI 0.675-0.966). Pearson's analysis also disclosed that SUA was positively correlated with ascending aortic diameter in total BDpatients. However, no difference of CRP (P = 0.219) or ESR (P = 0.320) between AAD patients and controls was observed, and no correlation of CRP (R = -0.150, P = 0.377) or ESR (R = 0.067, P = 0.692) with ascending aortic diameter in total BDpatients was discovered either. Further multivariate logistic regression illuminated that SUA was an independent factor predicting AAD risk in BDpatients (P = 0.031). CONCLUSIONS: Serum uric acid could be served as an independent marker for increased risk and severity of AAD in BDpatients.
Authors: Miguel A Quiñones; Catherine M Otto; Marcus Stoddard; Alan Waggoner; William A Zoghbi Journal: J Am Soc Echocardiogr Date: 2002-02 Impact factor: 5.251
Authors: Barış Güngör; Kazım Serhan Ozcan; Fatma Ozpamuk Karadeniz; Mahmut Uluganyan; Ahmet Ekmekçi; Ahmet Taha Alper; Damirbek Osmonov; Baran Karataş; Ercan Toprak; Izzet Celal Erdinler; Osman Bolca Journal: Turk Kardiyol Dern Ars Date: 2014-04
Authors: P Karimi; M Abbasalizad Farhangi; B Sarmadi; B P Gargari; A Zare Javid; M Pouraghaei; P Dehghan Journal: Ann Nutr Metab Date: 2015-12-12 Impact factor: 3.374
Authors: Antonio Greco; Armando De Virgilio; Massimo Ralli; Andrea Ciofalo; Patrizia Mancini; Giuseppe Attanasio; Marco de Vincentiis; Alessandro Lambiase Journal: Autoimmun Rev Date: 2018-04-06 Impact factor: 9.754
Authors: Anna Woźniacka; Anna Sysa-Jędrzejowska; Piotr Jurowski; Maciej Jabłkowski; Marek Kot Journal: Arch Med Sci Date: 2015-12-11 Impact factor: 3.318
Authors: Rishi J Desai; Jessica M Franklin; Julia Spoendlin-Allen; Daniel H Solomon; Goodarz Danaei; Seoyoung C Kim Journal: PLoS One Date: 2018-02-28 Impact factor: 3.240